Staff editor

Microbiome & Artificial Intelligence: The K4I 12th EU Innovation Summit report

A new study helps to explain how nerve cells sense the microbes in the gut and how they coordinate their function with other tissues in the digestive tract.

Microbiome, Big Data & Artificial Intelligence: The Future is now

A new study helps to explain how nerve cells sense the microbes in the gut and how they coordinate their function with other tissues in the digestive tract.

Innovative probiotic solutions in gynecology

We discussed the rationale of probiotics in urogenital female healthcare and after pregnancy with gynaecologist Franco Vicariotto.

The eleventh edition will be about

NEXT-GEN PROBIOTICS, PREBIOTICS AND POSTBIOTICS: WHO, WHAT & WHY? Probiotics This session will underline the advances of research and clinical applications of probiotics, stimulating the discussion on: Probiotics 2.0: new…

The Gut-Skin Axis: a probiotic complex solution to support skin distresses through oral intake

We discussed the dermobiotic approach with Marco Pignatti (Dermatologist, University of Modena, Italy).

Christophe Lacroix: ‘Our challenge is to culture anaerobic bacteria’

PharmaBiome has developed unique technologies to access the entire range of intestinal bacteria. We met Christophe Lacroix, Founder of Pharmabiome.

ProDigest customized solutions in gut microbiome research

ProDigest recreates the gastrointestinal tract to assess the mechanism of action of components such as prebiotics, probiotics or drugs.

Oral microbiome could play a role in head and neck cancer

We discussed the role of the microbiome in HPV-positive head and neck cancer patients with Marc Oliva Bernal (Institut Català d’Oncologia, Spain).

The Gut Microbiota: An Emerging Player in Breast Cancer

Does the microbiota contribute to breast cancer development? We asked this question to Sridhar Mani, from the Albert Einstein College of Medicine in New York (USA).

“There is a strong relationship between gut dysbiosis, metabolic diseases and cancer”

Rémy Burcelin explains how understanding the link between gut microbiota, metabolic syndrome and cancer could be useful from a therapeutic point of view.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top